APOLLOMICS INC (APLM) Stock Overview
USA - NASDAQ:APLM - KYG0411D1236 - Common Stock
APLM Key Statistics, Chart & Performance
The current stock price of APLM is 18.4331 USD. In the past month the price increased by 235.15%. In the past year, price increased by 42.67%.
APLM Latest News, Press Relases and Analysis
APLM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.77 | 407.19B | ||
| AMGN | AMGEN INC | 13.3 | 156.19B | ||
| GILD | GILEAD SCIENCES INC | 15.14 | 145.40B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.07 | 104.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.36B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.37 | 59.85B | ||
| ARGX | ARGENX SE - ADR | 85.97 | 48.77B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.17 | 35.16B | ||
| INSM | INSMED INC | N/A | 34.31B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.54B | ||
| NTRA | NATERA INC | N/A | 23.23B | ||
| BIIB | BIOGEN INC | 9.15 | 21.49B |
Related stock screener links
About APLM
Company Profile
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company is headquartered in Foster City, California and currently employs 13 full-time employees. The company went IPO on 2021-11-26. The product candidates in its pipeline are categorized into two groups based on their mechanisms of action, each of which contains product candidates at different stages of development: tumor inhibitors and immuno-oncology drugs. Its tumor inhibitor product candidates consist of three small-molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells: vebreltinib, APL-102 and APL-122. Its three immuno-oncology product candidates consist of APL-501, APL-502 and APL-80. Vebreltinib is a potent, oral active selective c-Met inhibitor. APL-102 is an oral active, small molecule Multiple Tyrosine Kinase Inhibitor. APL-122 is a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways. APL-501 is an anti-PD-1 antibody product candidate.
Company Info
APOLLOMICS INC
989 East Hillsdale Blvd, Ste 220
Foster City CALIFORNIA US
Employees: 13
Phone: 16502094055
APOLLOMICS INC / APLM FAQ
What is the stock price of APOLLOMICS INC today?
The current stock price of APLM is 18.4331 USD. The price increased by 51.34% in the last trading session.
What is the ticker symbol for APOLLOMICS INC stock?
The exchange symbol of APOLLOMICS INC is APLM and it is listed on the Nasdaq exchange.
On which exchange is APLM stock listed?
APLM stock is listed on the Nasdaq exchange.
What is APOLLOMICS INC worth?
APOLLOMICS INC (APLM) has a market capitalization of 20.28M USD. This makes APLM a Nano Cap stock.
How many employees does APOLLOMICS INC have?
APOLLOMICS INC (APLM) currently has 13 employees.
Is APOLLOMICS INC (APLM) expected to grow?
The Revenue of APOLLOMICS INC (APLM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the APLM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APOLLOMICS INC (APLM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APLM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APLM, evaluating the profitability, health, valuation and growth aspects
- APOLLOMICS INC (APLM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APOLLOMICS INC (APLM) Sales and EPS estimates to see what analysts future expectations are.
- APOLLOMICS INC (APLM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APOLLOMICS INC (APLM) Insider and Institutional Ownership to learn about the owners and their transactions.
- APOLLOMICS INC (APLM) Stock Chart to make your own analysis
- APOLLOMICS INC (APLM) Latest news and press-releases to stay up to date.
Does APOLLOMICS INC (APLM) stock pay dividends?
APLM does not pay a dividend.
What is the Price/Earnings (PE) ratio of APOLLOMICS INC (APLM)?
APOLLOMICS INC (APLM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).
APLM Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to APLM. When comparing the yearly performance of all stocks, APLM is one of the better performing stocks in the market, outperforming 97.31% of all stocks.
APLM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to APLM. Both the profitability and financial health of APLM have multiple concerns.
APLM Financial Highlights
Over the last trailing twelve months APLM reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -3757.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -311.63% | ||
| ROE | -418.59% | ||
| Debt/Equity | 0.01 |
APLM Forecast & Estimates
For the next year, analysts expect an EPS growth of 99.53% and a revenue growth -100% for APLM